Cited by 238Antibiotic Use and ResistanceAntibiotic Resistance in BacteriaAntimicrobial Resistance in Staphylococcus

Antibiotic resistance: turning evolutionary principles into clinical reality

Open access
Andersson, Dan I, Balaban, Nathalie Q, Baquero, Fernando, Courvalin, Patrice, Glaser, Philippe, Gophna, Uri, Kishony, Roy, Molin, Søren +1 more·2020·FEMS Microbiology Reviews

Abstract

Antibiotic resistance is one of the major challenges facing modern medicine worldwide. The past few decades have witnessed rapid progress in our understanding of the multiple factors that affect the emergence and spread of antibiotic resistance at the population level and the level of the individual patient. However, the process of translating this progress into health policy and clinical practice has been slow. Here, we attempt to consolidate current knowledge about the evolution and ecology of antibiotic resistance into a roadmap for future research as well as clinical and environmental control of antibiotic resistance. At the population level, we examine emergence, transmission and dissemination of antibiotic resistance, and at the patient level, we examine adaptation involving bacterial physiology and host resilience. Finally, we describe new approaches and technologies for improving diagnosis and treatment and minimizing the spread of resistance.

Integrity signals

Registry

Crossref · 10.1093/femsre/fuaa001

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • For immunocompromised cancer patients, multidrug-resistant infections can be life-threatening, with limited treatment options, prolonged hospital stays, and delayed or interrupted cancer therapy.

    “For immunocompromised cancer patients, MDR infections can be life-threatening, with limited treatment options, prolonged hospital stays, and delayed or interrupted cancer therapy [126]”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Andersson, D. I., Balaban, N. Q., Baquero, F., Courvalin, P., Glaser, P., Gophna, U., Kishony, R., Molin, S., & Tønjum, T.
Affiliations
  • Uppsala University (SE)
  • Hebrew University of Jerusalem (IL)
  • Department of Microbiology, Ramón y Cajal Health Research Institute, Ctra. Colmenar Viejo Km 9,100 28034 – Madrid, Madrid, Spain
  • Institut Pasteur (FR)
  • Tel Aviv University (IL)
  • Technion – Israel Institute of Technology (IL)
  • Novo Nordisk Foundation (DK)
  • Oslo University Hospital (NO)
Corresponding author
Gophna, Uri
Venue
FEMS Microbiology Reviews
Published
2020-01-25
Volume
44
Issue
2
Pages
171-188
ISSN
  • 0168-6445 (ISSN-L)
  • 1574-6976
OpenAlex
W3002094434
Cited by
238
References
5
Citations by year
2026: 21 · 2025: 30 · 2024: 38 · 2023: 41 · 2022: 48 · 2021: 40 · 2020: 20
FWCI
5.49
Type
journal article
Language
en
Open access
Locations
  • FEMS Microbiology Reviews (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion)
  • Technical University of Denmark, DTU Orbit (Technical University of Denmark, DTU) (submittedVersion)
  • NORA - Norwegian Open Research Archives (submittedVersion, other-oa)
Funders
European Academy of Microbiology
Topics
  • Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Antibiotic Use and Resistance
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Medicine › Antibiotic Resistance in Bacteria
  • Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
Keywords
antibiotic resistance, antibiotic resistance evolution, emergence of resistance, bacterial physiology, host resilience, resistance diagnosis, health policy
MeSH terms
Animals, Bacterial Infections, Humans, Preventive Medicine, Bacterial Physiological Phenomena, Evolution, Molecular, Drug Resistance, Bacterial

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review